Jefferies Group's TEVA Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 14,782 shares of Teva Pharmaceutical Industries Limited (TEVA) worth $461,346, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in TEVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 21,250 shares. Largest reduction occurred in Q1 2023, reducing 208,470 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +209,474 | New Buy | 209,474 | $9.12 |
| Q1 2023 | -208,470 | Reduce 99.52% | 1,004 | $8.85 |
| Q2 2023 | +15,523 | Add 1546.12% | 16,527 | $7.53 |
| Q3 2023 | -16,527 | Sold Out | 0 | $0.00 |
| Q2 2024 | +21,250 | New Buy | 21,250 | $16.25 |
| Q3 2024 | -21,250 | Sold Out | 0 | $0.00 |
| Q4 2024 | +15,048 | New Buy | 15,048 | $22.04 |
| Q1 2025 | -15,048 | Sold Out | 0 | $0.00 |
| Q4 2025 | +14,782 | New Buy | 14,782 | $31.21 |
Jefferies Group's Teva Pharmaceutical Industries Limited Investment FAQs
Jefferies Group first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, acquiring 209,474 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Teva Pharmaceutical Industries Limited (TEVA) for 9 quarters since Q4 2022.
Jefferies Group's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q4 2022, adding 209,474 shares worth $1.91 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 14,782 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $461,346.
As of the Q4 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 209,474 shares, as reported at the end of Q4 2022.